Talk on inactive X chromosome stability and sex-biased disease
The description says Dr. Daniel Andergassen's Milan Longevity Summit 2026 talk covers the inactive X chromosome, its stability over life, and possible links to ageing and sex-biased disease. [1]
Automatic summary · not editorially reviewed
The key findings
The description says Dr. Daniel Andergassen is a Group Leader at the Technical University of Munich, focusing on epigenetics, X chromosome biology, gene regulation and ageing. [1]
The description states that one X chromosome is largely silenced in female cells and that changes in its stability over life may influence gene regulation, ageing and disease susceptibility. [1]
The description says the presentation examines how X chromosome biology could offer insights into why certain neurological, autoimmune and age-related disorders differ between women and men. [1]
The source at a glance
- Study type / format
- Video description of a conference talk
- Population / context
- Female cells and women and men in the context of sex-biased disease, as described for the talk
- Summary based on
- Creator description
- Original publication
- August 8, 2026
Inactive X chromosome as the talk's focus
The description says this session from Decoding the Biology of Ageing at the Milan Longevity Summit 2026 features Dr. Daniel Andergassen. It states that one X chromosome is largely silenced in female cells, and that the talk explores the biology of this inactive X chromosome and its emerging role in ageing, health and sex-biased disease.
Supporting source [1]
Claimed links to ageing and disease differences
According to the description, growing evidence suggests that changes in the stability of the inactive X chromosome over the course of life may influence gene regulation, ageing and susceptibility to disease. The description further says the presentation examines how X chromosome biology could offer insights into why certain neurological, autoimmune and age-related disorders differ between women and men. These are described as possible influences and opportunities, not established causes.
Supporting source [1]
Speaker role and summit framing in the description
The description identifies Dr. Andergassen as Group Leader at the Technical University of Munich, where his research focuses on epigenetics, X chromosome biology, gene regulation and ageing. It says his work combines genomics, molecular biology and computational approaches to study how epigenetic regulation across the lifespan contributes to health, longevity and sex-specific disease risk. The summit is described as bringing together leaders from science, medicine, policy, business, technology and society under a One Health perspective.
Supporting source [1]
How to interpret this
This is based only on the video description; the video and transcript were not reviewed. The description gives no study design, sample, measured outcomes or results, and the described influences are presented as emerging possibilities, not established causes.
Based on the creator’s description; the full video and transcript were not analyzed.
Source & supporting passages
Milan Longevity Summit · youtube.com · August 8, 2026